| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.21 | 0.5 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.037 | 0.5 |